DE69233678T2 - Agglomerate mit hohem ibuprofen-gehalt und deren herstellungsverfahren - Google Patents

Agglomerate mit hohem ibuprofen-gehalt und deren herstellungsverfahren Download PDF

Info

Publication number
DE69233678T2
DE69233678T2 DE69233678T DE69233678T DE69233678T2 DE 69233678 T2 DE69233678 T2 DE 69233678T2 DE 69233678 T DE69233678 T DE 69233678T DE 69233678 T DE69233678 T DE 69233678T DE 69233678 T2 DE69233678 T2 DE 69233678T2
Authority
DE
Germany
Prior art keywords
agglomerates
isobutylphenyl
weight
propionic acid
starch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69233678T
Other languages
German (de)
English (en)
Other versions
DE69233678D1 (de
Inventor
Graham John Atkin
Peter Drew
John Leslie Turner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser Healthcare UK Ltd
Original Assignee
Reckitt Benckiser Healthcare UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare UK Ltd filed Critical Reckitt Benckiser Healthcare UK Ltd
Application granted granted Critical
Publication of DE69233678D1 publication Critical patent/DE69233678D1/de
Publication of DE69233678T2 publication Critical patent/DE69233678T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69233678T 1991-09-06 1992-08-25 Agglomerate mit hohem ibuprofen-gehalt und deren herstellungsverfahren Expired - Fee Related DE69233678T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919119052A GB9119052D0 (en) 1991-09-06 1991-09-06 Pharmaceutical compositions
GB9119052 1991-09-06
PCT/EP1992/001953 WO1993004676A1 (en) 1991-09-06 1992-08-25 High content ibuprofen agglomerates and process to prepare them

Publications (2)

Publication Number Publication Date
DE69233678D1 DE69233678D1 (de) 2007-03-22
DE69233678T2 true DE69233678T2 (de) 2008-01-24

Family

ID=10700981

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69233678T Expired - Fee Related DE69233678T2 (de) 1991-09-06 1992-08-25 Agglomerate mit hohem ibuprofen-gehalt und deren herstellungsverfahren

Country Status (16)

Country Link
US (1) US5512302A (OSRAM)
EP (1) EP0602112B1 (OSRAM)
JP (1) JP3444597B2 (OSRAM)
KR (1) KR100253046B1 (OSRAM)
AT (1) ATE353213T1 (OSRAM)
AU (1) AU655673B2 (OSRAM)
CA (1) CA2116956C (OSRAM)
CZ (1) CZ282271B6 (OSRAM)
DE (1) DE69233678T2 (OSRAM)
FI (1) FI107878B (OSRAM)
GB (1) GB9119052D0 (OSRAM)
IL (1) IL103005A (OSRAM)
IN (1) IN174169B (OSRAM)
RU (1) RU2123841C1 (OSRAM)
WO (1) WO1993004676A1 (OSRAM)
ZA (1) ZA926709B (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI101039B (fi) * 1992-10-09 1998-04-15 Eeva Kristoffersson Menetelmä lääkepellettien valmistamiseksi
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
HUP0104606A3 (en) * 1998-12-18 2003-01-28 Basf Ag A pharmaceutical mixture comprising a profen
US6726929B1 (en) 1998-12-18 2004-04-27 Basf Aktiengesellschaft Pharmaceutical mixture comprising a profen
US6251945B1 (en) * 1999-01-14 2001-06-26 Knoll Aktiengesellschaft Pharmaceutical mixture comprising a combination of a profen and other active compounds
DE19901692C2 (de) * 1999-01-18 2002-06-20 Gruenenthal Gmbh Verfahren zur Herstellung von Pellets mit einem Gehalt von bis zu 90 Gew.% eines pharmazeutischen Wirkstoffes
DE10003757A1 (de) * 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung
RU2164796C1 (ru) * 2000-05-25 2001-04-10 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Противогистаминное средство и способ его получения
US20040173147A1 (en) * 2001-06-07 2004-09-09 Figueroa Iddys D. Application of a bioactive agent to a delivery substrate
US6962715B2 (en) * 2001-10-24 2005-11-08 Hewlett-Packard Development Company, L.P. Method and dosage form for dispensing a bioactive substance
US20040173146A1 (en) * 2001-06-07 2004-09-09 Figueroa Iddys D. Application of a bioactive agent to a delivery substrate
DE10153934A1 (de) * 2001-11-06 2003-05-22 Basf Ag Verfahren zur Kristallisation von Profenen
GB0312419D0 (en) * 2003-05-30 2003-07-02 Boots Healthcare Int Ltd Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess
RU2254854C2 (ru) * 2003-09-08 2005-06-27 Открытое акционерное общество "Акционерное курганское общество медицинских препаратов и изделий "Синтез" Анальгезирующий, жаропонижающий, противовоспалительный препарат и способ его получения
US20050202051A1 (en) * 2004-03-15 2005-09-15 Chinea Vanessa I. Pharmaceutical vehicle
US20050203482A1 (en) * 2004-03-15 2005-09-15 Chinea Vanessa I. Pharmaceutical dispensing apparatus and method
JP2008266270A (ja) * 2007-04-25 2008-11-06 Kowa Co イブプロフェン、トラネキサム酸及び糖アルコールを含有する固形製剤
WO2016081523A1 (en) 2014-11-17 2016-05-26 Epizyme, Inc. Method for treating cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2058288T3 (es) * 1987-07-08 1994-11-01 American Home Prod Composiciones de ibuprofen secadas por atomizacion.
US5240712A (en) * 1987-07-17 1993-08-31 The Boots Company Plc Therapeutic agents
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
US4911921A (en) * 1989-02-02 1990-03-27 Mallinckrodt, Inc. High ibuprofen content granulations
US5266723A (en) * 1989-05-16 1993-11-30 Medice, Ltd., Chem.-Pharm. Fabrik Putter Gmbh & Co. Kg Process for the preparation of optically active 2-aryl-alkanoic acids, especially 2-aryl-propionic acids
US5087454A (en) * 1990-07-30 1992-02-11 American Home Products Corporation Ibuprofen tablet
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
US5332834A (en) * 1992-12-02 1994-07-26 Hoechst Celanese Corporation Racemization of an enantomerically enriched α-aryl carboxylic acid

Also Published As

Publication number Publication date
CZ49994A3 (en) 1994-07-13
RU2123841C1 (ru) 1998-12-27
IN174169B (OSRAM) 1994-10-01
AU655673B2 (en) 1995-01-05
US5512302A (en) 1996-04-30
AU2487092A (en) 1993-04-05
IL103005A (en) 1996-01-19
FI107878B (fi) 2001-10-31
JP3444597B2 (ja) 2003-09-08
EP0602112B1 (en) 2007-02-07
CZ282271B6 (cs) 1997-06-11
FI941046A0 (fi) 1994-03-04
IL103005A0 (en) 1993-01-31
WO1993004676A1 (en) 1993-03-18
KR100253046B1 (ko) 2000-05-01
GB9119052D0 (en) 1991-10-23
EP0602112A1 (en) 1994-06-22
ATE353213T1 (de) 2007-02-15
JPH06510532A (ja) 1994-11-24
DE69233678D1 (de) 2007-03-22
CA2116956A1 (en) 1993-03-18
CA2116956C (en) 2002-07-16
FI941046A7 (fi) 1994-03-04
ZA926709B (en) 1993-04-28

Similar Documents

Publication Publication Date Title
DE69233678T2 (de) Agglomerate mit hohem ibuprofen-gehalt und deren herstellungsverfahren
DE69231359T2 (de) Ibuprofen-salz enthaltende pharmazeutische zusammensetzung
Katta et al. Spherical crystallization of benzoic acid
DE60036205T2 (de) Granulat bestehend aus Stärke und Laktose
DE60114467T2 (de) Zubereitungen enthaltend ein steroidhormon und ein stabilisierungsmittel in nicht-kristalliner form
DE69629755T2 (de) Irbesartanhaltiges Arzneimittel
DE3877764T2 (de) Ein freifliessendes granulat, enthaltend ibuprofen und ein herstellunsgverfahren.
EP0119480B1 (de) Sphärische Einkristalle für pharmazeutische Zwecke
EP2054048A2 (de) Neue salze des wirkstoffs rasagilin
EP1250132B1 (de) Ibuprofen-wirkstoffzubereitung
DE69217554T2 (de) Ebastin oder ebastin-analoga enthaltende arzneimittel
AT399277B (de) Festes pharmazeutisches piroxicam-präparat und verfahren zu seiner herstellung
WO2012010669A2 (de) Arzneimittel zur oralen verabreichung umfassend ein gemisch aus silodosin und einem basischen copolymer
EP1077703A1 (de) Orale arzneiformen mit reproduzierbarer wirkstofffreisetzung von gatifloxacin oder pharmazeutisch verwendbaren salzen oder hydraten
EP2309995A1 (de) Pharmazeutische formulierung zur pulmonalen blutdrucksenkung
DE60212464T2 (de) Herstellung von tabletten von pharmazeutisch aktiven substanzen mit ungünstigen tablettierungseigenschaften mit einer mikrokristalline zellulose enthaltenden granulierflüssigkeit
DE69326470T2 (de) Wasserdispergierbare tabletten
DE60203498T2 (de) Komprimierbare Guaifenesin-Zusammensetzungen und deren Herstellungsverfahren
WO2011138037A2 (de) Festes tapentadol in nicht-kristalliner form
DE69734460T2 (de) Verfahren zur kristallisierung eines tetrahydropyridinderivates und die so erhaltenen kristallinen formen
DE10350528A1 (de) Arzneimittelformulierung, enthaltend einen LTB4-Antagonisten, sowie Verfahren zu deren Herstellung und deren Verwendung
DE2621906A1 (de) Neue therapeutische mischung und verfahren zu deren herstellung
DE60312635T2 (de) Zusammensetzung in Form einer festen Dispersion enthaltend Itraconazol und ein hydrophilisches Polymer mit einer verbesserten Bioverfügbarkeit
WO2009056288A2 (de) Stabilisierte statine
EP2638039A1 (de) Kristallines solifenacin-succinat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee